Akebia Therapeutics, Inc. To Present At The 2015 UBS Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that John P. Butler, President and Chief Executive Officer, will present at the 2015 UBS Global Healthcare Conference on Monday, May 18, 2015, at 9:30 a.m. Eastern Time. The conference is being held at The Sheraton New York Hotel in New York City.

Help employers find you! Check out all the jobs and post your resume.